Sodium Oxybate
Links shared publicly online about this topic
Sodium Oxybate & Sleep in Fibromyalgia
chronicfatigue.about.com — “Sodium Oxybate & Sleep in Fibromyalgia” View full resource at chronicfatigue.about.com
Most Recently Shared on August 9, 2010 at 9:14 pm By:
Sodium Oxybate & Sleep in Fibromyalgia http://bit.ly/aq42UK
Sodium Oxybate for Fibromyalgia: Data are Promising
chronicfatigue.about.com — “Sodium Oxybate for Fibromyalgia: Data are Promising” View full resource at chronicfatigue.about.com
Most Recently Shared on June 18, 2009 at 8:36 pm By:
Sodium Oxybate for Fibromyalgia: Data are Promising - About - News & Issues http://tinyurl.com/mzhehz
Sodium Oxybate for Fibromyalgia: New Results Released
chronicfatigue.about.com — “Sodium Oxybate for Fibromyalgia: New Results Released” View full resource at chronicfatigue.about.com
Most Recently Shared on June 25, 2009 at 8:40 pm By:
Sodium Oxybate for Fibromyalgia: New Results Released http://tinyurl.com/kt2zwy
ingentaconnect Sodium oxybate: Sleep apnoea: case report
ingentaconnect.com — “ingentaconnect Sodium oxybate: Sleep apnoea: case report” View full resource at ingentaconnect.com
Most Recently Shared on March 22, 2012 at 1:22 am By:
Sodium oxybate: Sleep apnoea: case report: (Source: Reactions) http://t.co/rR9R7LvA
Sodium oxybate improves symptoms of fibromyalgia - JAAPA
jaapa.com — “Clinical question: Does sodium oxybate improve symptoms in patients with fibromyalgia?” View full resource at jaapa.com
Most Recently Shared on January 28, 2010 at 5:43 am By:
Sodium oxybate improves symptoms of fibromyalgia - Journal of the American Academy of Physician Assistants http://tinyurl.com/cmbssh
Sodium Oxybate Reduces Fibromyalgia Pain and Fatigue
medworm.com — “: Sodium oxybate, an investigational metabolite of gamma-aminobutyric acid, targets deep sleep disturbances common in fibromyalgia patients, reducing fatigue and pain.” View full resource at medworm.com
Most Recently Shared on October 29, 2009 at 4:23 am By:
Sodium Oxybate Reduces Fibromyalgia Pain and Fatigue http://bit.ly/1QcRC
Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia
medicalnewstoday.com — “Jazz pharmaceuticals' (nasdaq: jazz) sodium oxybate (jzp-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2009 at 12:42 am By:
Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia http://tinyurl.com/lec75f
ingentaconnect Sodium oxybate: Acute depression and suicidal ideation: case repo...
ingentaconnect.com — “ingentaconnect Sodium oxybate: Acute depression and suicidal ideation: case repo...” View full resource at ingentaconnect.com
Most Recently Shared on September 27, 2010 at 12:26 am By:
Depression Wisdom Active Health Library and OW Health
Sodium oxybate: Acute depression and suicidal ideation: case report: (Source: Reactions) http://bit.ly/cWNStI
Sodium Oxybate for Fibromyalgia Does Well in First International Trial
medworm.com — “: A placebo-controlled study of sodium oxybate resulted in a clinically relevant reduction in pain of more than 30% and significant improvements in quality of life and sleep.” View full resource at medworm.com
Most Recently Shared on February 13, 2010 at 4:45 am By:
Sodium Oxybate for Fibromyalgia Does Well in First International Phase 3 Trial http://bit.ly/aKJcus
FDA Panel Says No to Sodium Oxybate for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 23, 2010 at 12:36 pm By:
FDA Panel Says No to Sodium Oxybate for Fibromyalgia: A joint FDA advisory committee has voted against approval of... http://bit.ly/cyQMki
Second Phase 3 study of sodium oxybate for fibromyalgia pain - MPR
empr.com — “Jazz Pharmaceuticals and UCB announced positive preliminary top-line results from the second of two Phase 3 clinical trials of sodium oxybate (JZP-6) for the treatment of fibromyalgia.” View full resource at empr.com
Most Recently Shared on June 25, 2009 at 6:40 pm By:
MPR News: Second Phase 3 study of sodium oxybate for fibromyalgia pain: Jazz Pharmaceuticals and UCB an.. http://tinyurl.com/nlhxsd
Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences | Reuters
reuters.com — “Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences PALO ALTO, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Jazz” View full resource at reuters.com
Most Recently Shared on October 15, 2009 at 3:29 am By:
Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in ... - Reuters http://bit.ly/7lC3z
Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia
medicalnewstoday.com — “Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for JZP-6 (sodium oxybate oral solution) for the treatmen” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2009 at 11:17 am By:
MNT Clinical Trials Health News
Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia http://mnt.to/3vxc
Fibromyalgia New Drug Application JZP-6 (Sodium Oxybate) Turned Down By FDA
medicalnewstoday.com — “JZP-6 (Sodium Oxybate), a new drug for the treatment of fibromyalgia has been turned down by the Food and Drug Administration (FDA) in a response letter to an NDA (new drug application), saying th” View full resource at medicalnewstoday.com
Most Recently Shared on October 11, 2010 at 6:13 pm By:
Fibromyalgia New Drug Application JZP-6 (Sodium Oxybate) Turned Down By FDA http://sns.ly/f0y57
Jazz Pharmaceuticals Announces FDA Acceptance Of Its New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia
medicalnewstoday.com — “Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treat” View full resource at medicalnewstoday.com
Most Recently Shared on February 20, 2010 at 4:06 pm By:
MNT Clinical Trials Health News
Jazz Pharmaceuticals Announces FDA Acceptance Of Its New Drug Application For JZP-6 (sodium Oxybate) For The Treatment... http://mnt.to/3xTG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
Advertisement
